Published in Medical Letter on the CDC and FDA, April 5th, 2009
"Eligible patients had unresectable, biopsy-proven HCC and had not...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.